Shanghai RAAS Blood Products Co Ltd Class A (002252) — Cash Flow-to-Debt Ratio
Shanghai RAAS Blood Products Co Ltd Class A (002252) has a Cash Flow-to-Debt Ratio of -0.16x as of December 2025, meaning its operating cash flow of CN¥-843.75 Million could theoretically repay 0% of its total liabilities (CN¥5.33 Billion) in one year. Check cash flow reinvestment rate of Shanghai RAAS Blood Products Co Ltd Clas to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai RAAS Blood Products Co Ltd Class A Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Shanghai RAAS Blood Products Co Ltd Class A across 21 annual periods. Also explore balance sheet size of Shanghai RAAS Blood Products Co Ltd Clas for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)
Year-by-year debt coverage analysis for Shanghai RAAS Blood Products Co Ltd Class A. For market capitalisation and broader financial context, see Shanghai RAAS Blood Products Co Ltd Clas (002252) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.02x | CN¥-104.89 Million | CN¥5.34 Billion | ▲ +93.1% |
| 2024 | -0.29x | CN¥-482.06 Million | CN¥1.69 Billion | ▼ -128.5% |
| 2023 | 1.00x | CN¥2.28 Billion | CN¥2.28 Billion | ▼ -4.7% |
| 2022 | 1.05x | CN¥1.73 Billion | CN¥1.64 Billion | ▲ +8.0% |
| 2021 | 0.97x | CN¥1.29 Billion | CN¥1.33 Billion | ▼ -69.8% |
| 2020 | 3.21x | CN¥1.17 Billion | CN¥363.74 Million | ▲ +33.3% |
| 2019 | 2.41x | CN¥872.69 Million | CN¥361.95 Million | ▲ +356.1% |
| 2018 | 0.53x | CN¥262.50 Million | CN¥496.56 Million | ▲ +288.5% |
| 2017 | 0.14x | CN¥268.76 Million | CN¥1.98 Billion | ▼ -68.1% |
| 2016 | 0.43x | CN¥638.22 Million | CN¥1.50 Billion | ▼ -52.8% |
| 2015 | 0.90x | CN¥762.42 Million | CN¥843.64 Million | ▲ +46.5% |
| 2014 | 0.62x | CN¥465.96 Million | CN¥755.16 Million | ▲ +424.2% |
| 2013 | -0.19x | CN¥-90.11 Million | CN¥473.37 Million | ▼ -113.6% |
| 2012 | 1.40x | CN¥263.46 Million | CN¥188.79 Million | ▼ -35.5% |
| 2011 | 2.16x | CN¥178.03 Million | CN¥82.26 Million | ▲ +7.1% |
| 2010 | 2.02x | CN¥200.21 Million | CN¥99.12 Million | ▲ +7.8% |
| 2009 | 1.87x | CN¥116.01 Million | CN¥61.88 Million | ▲ +33.1% |
| 2008 | 1.41x | CN¥107.64 Million | CN¥76.42 Million | ▲ +9.4% |
| 2007 | 1.29x | CN¥175.71 Million | CN¥136.53 Million | ▲ +304.4% |
| 2006 | 0.32x | CN¥53.58 Million | CN¥168.39 Million | ▼ -39.9% |
| 2005 | 0.53x | CN¥54.02 Million | CN¥101.93 Million | — |